Cathie Wood’s ARK Invest Makes Strategic Moves in Fintech and Biotech
Cathie Wood's ARK Invest ETFs executed significant trades on August 19, capitalizing on recent price declines to bolster positions in Robinhood Markets, CRISPR Therapeutics, and BEAM Therapeutics. The ARK Innovation ETF acquired $17 million worth of HOOD shares, now representing 4.29% of its combined portfolio.
ARK simultaneously divested $8.6 million in Tempus AI and $2.8 million in Genius Sports, marking a strategic rotation within its innovation-focused holdings. These moves demonstrate Wood's conviction in disruptive technologies despite short-term market volatility.